169 related articles for article (PubMed ID: 12017339)
1. Role of thymic stromal cell dysfunction in the thymic involution of mammary tumor-bearing mice.
Sun QL; Charyulu V; Lobo D; Lopez DM
Anticancer Res; 2002; 22(1A):91-6. PubMed ID: 12017339
[TBL] [Abstract][Full Text] [Related]
2. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas.
Fu Y; Paul RD; Wang Y; Lopez DM
J Immunol; 1989 Dec; 143(12):4300-7. PubMed ID: 2592775
[TBL] [Abstract][Full Text] [Related]
3. Impaired thymopoiesis occurring during the thymic involution of tumor-bearing mice is associated with a down-regulation of the antiapoptotic proteins Bcl-XL and A1.
Carrio R; Lopez DM
Int J Mol Med; 2009 Jan; 23(1):89-98. PubMed ID: 19082511
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of interleukin-7 and hepatocyte growth factor in the thymic microenvironment is associated with thymus involution in tumor-bearing mice.
Carrio R; Altman NH; Lopez DM
Cancer Immunol Immunother; 2009 Dec; 58(12):2059-72. PubMed ID: 19421751
[TBL] [Abstract][Full Text] [Related]
5. Epidermal Langerhans cells from mice bearing a granulocyte macrophage-colony stimulating factor-producing mammary tumor display impaired accessory functions.
Xie Y; Fernandez ME; Streilein JW; Lopez DM
Anticancer Res; 1996; 16(1):9-16. PubMed ID: 8615675
[TBL] [Abstract][Full Text] [Related]
6. Thymic atrophy induced by murine mammary adenocarcinoma in vivo.
Fu YX; Altman N; Lopez DM
In Vivo; 1989; 3(1):1-5. PubMed ID: 2519827
[TBL] [Abstract][Full Text] [Related]
7. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
[TBL] [Abstract][Full Text] [Related]
8. Tumor-induced thymic atrophy: alteration in interferons and Jak/Stats signaling pathways.
Carrio R; Torroella-Kouri M; Iragavarapu-Charyulu V; Lopez DM
Int J Oncol; 2011 Feb; 38(2):547-53. PubMed ID: 21165556
[TBL] [Abstract][Full Text] [Related]
9. GM-CSF up-regulates the expression of CCL2 by T lymphocytes in mammary tumor-bearing mice.
Owen JL; Torroella-Kouri M; Handel-Fernandez ME; Iragavarapu-Charyulu V
Int J Mol Med; 2007 Jul; 20(1):129-36. PubMed ID: 17549399
[TBL] [Abstract][Full Text] [Related]
10. Early block in maturation is associated with thymic involution in mammary tumor-bearing mice.
Adkins B; Charyulu V; Sun QL; Lobo D; Lopez DM
J Immunol; 2000 Jun; 164(11):5635-40. PubMed ID: 10820238
[TBL] [Abstract][Full Text] [Related]
11. Induction of granulocytic hyperplasia, thymic atrophy, and hypercalcemia by a selected subpopulation of a murine mammary adenocarcinoma.
Thomas E; Smith DC; Lee MY; Rosse C
Cancer Res; 1985 Nov; 45(11 Pt 2):5840-4. PubMed ID: 4053054
[TBL] [Abstract][Full Text] [Related]
12. Thymic dependency of the humoral regulation of CFU-s proliferation in mice bearing a CSF-producing tumor.
Lepault F; Fache MP; Frindel E
Int J Cell Cloning; 1988 Jul; 6(4):262-80. PubMed ID: 3047267
[TBL] [Abstract][Full Text] [Related]
13. Influence of breast cancer on thymic function in mice.
Lopez DM; Charyulu V; Adkins B
J Mammary Gland Biol Neoplasia; 2002 Apr; 7(2):191-9. PubMed ID: 12463739
[TBL] [Abstract][Full Text] [Related]
14. T-cell recruitment from the thymus to the spleen in tumor bearing mice: phenotypical alteration and recruitment of thymocytes raised in a tumor bearing state.
Tanaka K; Koga Y; Taniguchi K; Nomoto K
Cancer Res; 1987 Apr; 47(8):2136-41. PubMed ID: 3493841
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin.
Bhattacharyya S; Mandal D; Sen GS; Pal S; Banerjee S; Lahiry L; Finke JH; Tannenbaum CS; Das T; Sa G
Cancer Res; 2007 Jan; 67(1):362-70. PubMed ID: 17210719
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice.
Abe F; Dafferner AJ; Donkor M; Westphal SN; Scholar EM; Solheim JC; Singh RK; Hoke TA; Talmadge JE
Cancer Immunol Immunother; 2010 Jan; 59(1):47-62. PubMed ID: 19449184
[TBL] [Abstract][Full Text] [Related]
17. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
Buessow SC; Paul RD; Lopez DM
J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
[TBL] [Abstract][Full Text] [Related]
18. Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice.
Owen JL; Torroella-Kouri M; Iragavarapu-Charyulu V
Int J Mol Med; 2008 Jan; 21(1):125-34. PubMed ID: 18097625
[TBL] [Abstract][Full Text] [Related]
19. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
[TBL] [Abstract][Full Text] [Related]
20. Immunopotentiation in mice bearing a spontaneous transplantable T-cell lymphoma: role of thymic extract.
Shanker A; Singh SM
Neoplasma; 2003; 50(4):272-9. PubMed ID: 12937840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
